We care, for the better.
A place for professionals to develop innovative practice, connect with their peers and put families first.
Support Adfam and receive our policy briefings.
You have successfully signed up to receive our policy briefing.
On Twitter? Get up to date information directly to your feed. Follow @AdfamUK.
Opioid Substitute Medications in Drug Treatment: Tackling the Risks to Children
4 Jun 2015
Adfam are offering local authorities the opportunity to work with us to help reduce the risks posed to children by opioid substitution therapy medications.
In April 2014 Adfam published Medications in Drug Treatment: Tackling the risks to children (pdf); a report examining cases where children had come to harm or died as a result of ingesting opioid substitution therapy (OST) medications, and making recommendations for policy and practice to address this risk. The writing of a ‘Year +1’ report is now underway, looking at the progress made in adopting the recommendations of the original report and further highlighting good practice.
Since 2003, there have been 23 serious case reviews where OST drugs were ingested by a child – 18 of which were fatal.
This is an exciting opportunity for local authorities across England and Wales to help prevent these tragedies from happening again by working with Adfam to help locally implement best practice in safeguarding children from the risks posed by OST medications.